Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Kilbourn

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxideR G Kilbourn, S S Gross, A Jubran, et al.
The Journal of Biological Chemistry|May 12, 1995
S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivoK Narayanan, L Spack, K McMillan, et al.
Biochemical and Biophysical Research Communications|November 15, 1990
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisR G Kilbourn, A Jubran, S S Gross, et al.
Anesthesiology|July 1, 1996
Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogsJ E Chelly, M F Doursout, T Lechevalier, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Critical Care Medicine|June 1, 1995
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotensionR G Kilbourn, G A Fonseca, O W Griffith, et al.
The American Journal of Physiology|January 1, 1996
Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremiaW Lingnau, R McGuire, D J Dehring, et al.
Journal of the National Cancer Institute|July 1, 1992
Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginineR G Kilbourn, S S Gross, R F Lodato, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxideR G Kilbourn, S S Gross, A Jubran, et al.
The Journal of Biological Chemistry|May 12, 1995
S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivoK Narayanan, L Spack, K McMillan, et al.
Biochemical and Biophysical Research Communications|November 15, 1990
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisR G Kilbourn, A Jubran, S S Gross, et al.
Anesthesiology|July 1, 1996
Cardiac and regional hemodynamic interactions between halothane and nitric oxide synthase activity in dogsJ E Chelly, M F Doursout, T Lechevalier, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Critical Care Medicine|June 1, 1995
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotensionR G Kilbourn, G A Fonseca, O W Griffith, et al.
The American Journal of Physiology|January 1, 1996
Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremiaW Lingnau, R McGuire, D J Dehring, et al.
Journal of the National Cancer Institute|July 1, 1992
Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginineR G Kilbourn, S S Gross, R F Lodato, et al.
Pageof 5